Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?

Diabetes, obesity, metabolism and SARS-CoV-2 infection: The end of the beginning

(2021) Daniel J. Drucker   Cell Metabolism

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study

(2020) Amitava Banerjee et al.   LANCET

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019

(2020) Shivani Agarwal et al.   DIABETES CARE

The protein expression profile of ACE2 in human tissues

(2020) Feria Hikmet et al.   Molecular Systems Biology

Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?

(2020) Sascha René Tittel et al.   DIABETES CARE

COVID-19 and Children With Diabetes—Updates, Unknowns, and Next Steps: First, Do No Extrapolation

(2020) Linda A. DiMeglio et al.   DIABETES CARE

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.

(2020) Rebecca Unsworth et al.   DIABETES CARE

Proportion of newly diagnosed diabetes in COVID ‐19 patients: A systematic review and meta‐analysis

(2020) Thirunavukkarasu Sathish et al.   DIABETES OBESITY & METABOLISM